Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Macrocytosis and cobalamin deficiency in patients treated with sunitinib.

× No keyword cloud information.

7 in total

1. A Case of Cobalamin Deficiency and Macrocytic Anemia Secondary to Sunitinib.

Authors: Jarred P Reed; Joan Chung; Natasha Banerjee
Journal: Cureus Date: 2019-03-25

2. Continuous Sunitinib treatment in patients with advanced hepatocellular carcinoma: a Swiss Group for Clinical Cancer Research (SAKK) and Swiss Association for the Study of the Liver (SASL) multicenter phase II trial (SAKK 77/06).

Authors: Dieter Koeberle; Michael Montemurro; Panagiotis Samaras; Pietro Majno; Mathew Simcock; Andreas Limacher; Stefanie Lerch; Katalin Kovàcs; Roman Inauen; Vivianne Hess; Piercarlo Saletti; Markus Borner; Arnaud Roth; György Bodoky
Journal: Oncologist Date: 2010-03-04

3. Sunitinib causes macrocytosis in patients with advanced renal cell carcinoma.

Authors: J Price; R Shaarbaf; L Wood
Journal: Curr Oncol Date: 2010-04 Impact factor: 3.677

4. Sunitinib-Induced Elevation of Mean Corpuscular Volume (MCV)-Exploring Its Possible Clinical Relevance in Cancer Patients.

Authors: Michal Rihacek; Iveta Selingerova; Ivo Kocak; Ilona Kocakova; Eva Rihackova; Dalibor Valik; Jaroslav Sterba
Journal: Curr Oncol Date: 2022-06-07 Impact factor: 3.109

5. Blood glucose levels in patients with metastatic renal cell carcinoma treated with sunitinib.

Authors: B Billemont; J Medioni; L Taillade; D Helley; J B Meric; O Rixe; S Oudard
Journal: Br J Cancer Date: 2008-10-07 Impact factor: 7.640

6. Macrocytosis during sunitinib treatment predicts progression-free survival in patients with metastatic renal cell carcinoma.

Authors: Jakub Kucharz; Agnieszka Giza; Paulina Dumnicka; Marek Kuzniewski; Beata Kusnierz-Cabala; Pawel Bryniarski; Roma Herman; Aneta Lidia Zygulska; Krzysztof Krzemieniecki
Journal: Med Oncol Date: 2016-08-30 Impact factor: 3.064

7. Sunitinib as salvage treatment including potent anti-tumor activity in carcinomatous ulcers for patients with multidrug-resistant metastatic breast cancer.

Authors: Bing Sun; Xin Zhao; Lijuan Ding; Xiangying Meng; Santai Song; Shikai Wu
Journal: Oncotarget Date: 2016-09-06

7 in total